Merck KGaA opens BioReliance Biodevelopment Center in Shanghai

The center offers competencies and services for bioprocess development, e. g., for the development of cell lines, and upstream and downstream processes. Target customers are SMEs in the Asia-Pacific region which work on clinical studies in an early phase.

China Bio news release, September 27, 2017

Most popular posts: